2022
Association of iron infusion reactions with ABO blood type
Butt A, Muradashvili T, Soliman S, Li F, Burns AJ, Brooks A, Browning S, Bar N, Borgman G, Goshua G, Hwa J, Martin K, Rinder H, Tormey C, Pine AB, Bona RD, Lee AI, Neparidze N. Association of iron infusion reactions with ABO blood type. European Journal Of Haematology 2022, 109: 519-525. PMID: 35871468, DOI: 10.1111/ejh.13838.Peer-Reviewed Original ResearchConceptsGreater oddsBlood typeYale Cancer CenterInfusion-related reactionsRetrospective chart reviewLarger patient numbersABO blood typeType AB bloodChart reviewInfusion reactionsMost patientsHematology clinicIron sucroseMultivariable analysisProspective studyCancer CenterPatient numbersIron dextranRisk factorsIron infusionIron repletionPatientsPossible associationAB bloodBlood
2019
Daratumumab in the Clinic, a Real-Word Experience at Yale Cancer Center
Browning S, Parker T, Bar N, Seropian S, Lee A, Anderson T, Neparidze N. Daratumumab in the Clinic, a Real-Word Experience at Yale Cancer Center. Blood 2019, 134: 5569. DOI: 10.1182/blood-2019-130134.Peer-Reviewed Original ResearchSmilow Cancer HospitalMultiple myelomaRefractory MMInfusion reactionsSpeakers bureauCancer HospitalReal-word experienceReal-world practice patternsAnti-plasma cell therapyTransplant-eligible patientsYale Cancer CenterInfusion-related reactionsAdverse event profileLeukotriene receptor antagonistsProgression-free survivalRefractory multiple myelomaPatient-reported qualityManagement of patientsOverall response rateJanssen Scientific AffairsClonal plasma cellsExcellent safety profileMulti-center studyDrug combination regimensInfusion reaction rates
2014
Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit
Kim R, Yao X, Longley P, Rimar J, Kournioti C, Lee A. Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit. Blood 2014, 124: 1302. DOI: 10.1182/blood.v124.21.1302.1302.Peer-Reviewed Original ResearchRothman IndexHematologic malignanciesReadmission ratesMedical recordsRA ratesYale Cancer CenterHematology-oncology patientsInpatient oncology unitCommon hematologic malignancyNon-Hodgkin lymphomaAcute myeloid leukemiaHealth care providersHealth care costsElectronic medical recordsDischarge dispositionHospitalized patientsMedian ageHematology unitHM patientsNursing assessmentOncology unitCancer CenterMultiple myelomaMyeloid leukemiaIndividual patients